检索结果-南通市图书馆

Chinese Chemical Letters 2011年第3期22卷 362-365页

作者： shu rong wang ling jun zhu ying ying zhu xiao lan ge xin bao li State Key Laboratory of Clean Energy Utilization Zhejiang University Hangzhou 310027 China

The Cu/SiO_2 catalysts were in situ synthesized by the hydrolysis of tetraethyl orthosilicate（TEOS） in one phase solution using ethanol as co-solvent or TEOS/H_2O two phases solution,followed by the precipitation of copper on SiO_2 by ammonia evaporation. In the hydrogenation of dimethyl oxalate,the catalyst prepared by one phase hydrolysis exhibited higher activity and ethylene glycol（EG） selectivity at lower temperature than that of two phases due to its larger BET surface area and multimodal pore *** 488-503 K,the catalyst prepared in one phase solution with water/ethanol（W/E） volume ratio of 3：1 exhibited 90- 95%EG selectivity,while catalyst prepared by two phase hydrolysis reached 90%EG selectivity only at 498-503 K.

关键词： Ethanol Cu/SiO2 TEOS Hydrogenation Dimethyl oxalate Ethylene glycol

CEPC Technical Design Report

在线全文

学校读者我要写书评

暂无评论

Radiation Detection Technology and Methods 2024年第1期8卷 I0003-I0016,1-1091页

作者： Waleed Abdallah Tiago Carlos Adorno de Freitas Konstantin Afanaciev Shakeel Ahmad Ijaz Ahmed xiaocong Ai Abid Aleem Wolfgang Altmannshofer Fabio Alves Weiming An Rui An Daniele Paolo Anderle Stefan Antusch Yasuo Arai Andrej Arbuzov Abdesslam Arhrib Mustafa Ashry Sha Bai Yu Bai Yang Bai Vipul Bairathi Csaba Balazs Philip Bambade Yong Ban Tripamo Bandyopadhyay Shou-Shan bao Desmond P.Barber Ayse Bat Varvara Batozskaya Subash Chandra Behera Alexander Belyaev Michele Bertucci xiao-jun Bi Yuanjie Bi Tianjian Bian Fabrizio Bianchi Thomas Biekotter Michela Biglietti Shalva Bilanishvili Deng Binglin Denis Bodrov Anton Bogomyagkov Serge Bondarenko Stewart Boogert Maarten Boonekamp Marcello Borri Angelo Bosotti Vincent Boudry Mohammed Boukidi Igor Boyko Ivanka Bozovic Giuseppe Bozzi Jean-Claude Brient Anastasiia Budzinskaya Masroor Bukhari Vladimir Bytev Giacomo Cacciapaglia Hua Cai Wenyong Cai Wujun Cai Yijian Cai Yizhou Cai Yuchen Cai Haiying Cai Huacheng Cai Lorenzo Calibbi junsong Cang Guofu Cao Jianshe Cao Antoine Chance Xuejun Chang Yue Chang Zhe Chang xinyuan Chang Wei Chao Auttakit Chatrabhuti Yimin Che Yuzhi Che Bin Chen Danping Chen Fuqing Chen Fusan Chen Gang Chen Guoming Chen Hua-xing Chen Huirun Chen Jinhui Chen Ji-Yuan Chen Kai Chen Mali Chen Mingjun Chen Mingshui Chen Ning Chen Shanhong Chen Shanzhen Chen Shao-Long Chen Shaomin Chen Shiqiang Chen Tianlu Chen Wei Chen Xiang Chen xiaoyu Chen xin Chen Xun Chen Xurong Chen Ye Chen ying Chen Yukai Chen Zelin Chen Zilin Chen Gang Chen Boping Chen Chunhui Chen Hok Chuen Cheng Huajie Cheng Shan Cheng Tongguang Cheng Yunlong Chi Pietro Chimenti Wen Han Chiu Guk Cho Ming-Chung Chu xiaotong Chu Ziliang Chu Guglielmo Coloretti Andreas Crivellin Hanhua Cui xiaohao Cui Zhaoyuan Cui Brunella D'Anzi ling-Yun Dai xinchen Dai Xuwen Dai Antonio De Maria Nicola De Filippis Christophe De La Taille Francesca De Mori Chiara De Sio Elisa Del Core shuangxue Deng Wei-Tian Deng Zhi Deng Ziyan Deng Bhupal Dev Tang Dewen Biagio Di Micco Ran Ding Siqin Dingl Yadong Ding Haiyi Dong Jianin AGH University of Science and Technology Faculty of Physics and Applied Computer ScienceKrakow Anhui University HefeiAnhui Applied Physics Department Federal Urdu University of ArtsScience and TechnologyIslamabad Banaras Hindu University Institute of ScienceVaranasi Bandirma Onyedi Eylul University Bandirma Beihang University Beijing Beijing Computational Science Research Center Beijing Beijing Conveyi LTD Beijing Beijing Glass Research Institute Co. LtdBeijing Beijing Institute of Technology Beijing Beijing Normal University Beijing Brown University ProvidenceRI Budker Institute of Nuclear Physics Novosibirsk Cadi Ayyad University Laboratory of Fundamental and Applied PhysicsPolydisciplinary FacultyMarrakech Cairo University Giza Center for Theory and Computation National Tsing Hua UniversityHsinchu Central China Normal University WuhanHubei Central South University ChangshaHunan Centro de Fisica Teorica de Particulas Universidade Tecnica de LisboaLisboa Chengdu KaitengSifang Digital Radio&TV Equipment Co. LtdChengduSichuan China academy of engineering physics MianyangSichuan China building materials academy Beijing China Center of Advanced Science and Technology Beijing China Institute of Atomic Energy Beijing China Jiliang University HangzhouZhejiang China Nuclear Instrument CO. LTDBeijing China University of geosciences Beijing China University of geosciences WuhanHubei China University of Mining and Technology XuzhouJiangsu China West Normal University NanchongSichuan Chongqing University Department of PhysicsChongqing Chulalongkorn University Bangkok City University of Hong Kong Department of PhysicsHong Kong Cockcroft Institute Daresbury Cornell University IthacaNY CPPM(AMU/IPhU&CNRS/INP) Marseille Dalian Minzu University DalianLiaoning Dalian University of Technology Department of PhysicsDalian Deutsches Elektronen-Synchrotron DESY Hamburg Dzhelepov Laboratory of Nuclear Problems of Joint Institute for Nuclear Research(DLNP JINR) Dubna East China University Of Science And Technol

The Circular Electron Positron Collider(CEPC)is a large scientific project initiated and hosted by China,fostered through extensive collaboration with international *** complex comprises four accelerators:a 30 geV linac,a 1.1 geV Damping Ring,a Booster capable of achieving energies up to 180 geV,and a Collider operating at varying energy modes(Z,W,H,and tt).The linac and Damping Ring are situated on the surface,while the subterranean Booster and Collider are housed in a 100 km circumference underground tunnel,strategically accommodating future expansion with provisions for a potential Super Proton Proton Collider(SPPC).The CEPC primarily serves as a Higgs *** its baseline design with synchrotron radiation(SR)power of 30 MW per beam,it can achieve a luminosity of 5×10^(34)cm^(-2)s^(-1)per interaction point(IP),resulting in an integrated luminosity of 13 ab^(-1)for two IPs over a decade,producing 2.6 million Higgs *** the SR power to 50 MW per beam expands the CEPC's capability to generate 4.3 million Higgs bosons,facilitating precise measurements of Higgs coupling at sub-percent levels,exceeding the precision expected from the HL-LHC by an order of *** Technical Design Report(TDR)follows the Preliminary Conceptual Design Report(Pre-CDR,2015)and the Conceptual Design Report(CDR,2018),comprehensively detailing the machine's layout,performance metrics,physical design and analysis,technical systems design,R&D and prototyping efforts,and associated civil engineering ***,it includes a cost estimate and a preliminary construction timeline,establishing a framework for forthcoming engineering design phase and site selection *** is anticipated to begin around 2027-2028,pending government approval,with an estimated duration of 8 *** commencement of experiments and data collection could potentially be initiated in the mid-2030s.

关键词： initiated exceeding precise

Safety and efficacy of thalidomide in patients with transfusiondependentβ-thalassemia:a randomized clinical trial

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Signal Transduction and Targeted Therapy 2021年第12期6卷 3723-3729页

作者： Jiang-Ming Chen Wei-Jian zhu Jie liu Gui-Zhen wang xiao-Qin Chen Yun Tan Wei-Wei Xu li-Wei Qu Jin-Yan li Huan-Ju Yang lan Huang Ning Cai Wei-Da wang Ken Huang Jian-Quan Xu Guo-Hui li Sheng He Tian-ying Luo Yi Huang Song-Hua liu Wen-Qiang Wu Qi-Yang Lu Mei-Guang Zhou shu-ying Chen rong-lan li Mei-ling Hu ying Huang Jin-Hua Wei jun-Min li Sai-Juan Chen Guang-Biao Zhou Department of Hematology Wuzhou Gongren HospitalWuzhou 543001 GuangxiChina Department of Hematology Zhuhai People’s Hospital(Zhuhai Hospital Affiliated with Jinan University)Zhuhai 541000 GuangdongChina State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China Department of Reproductive Medicine The First Affiliated Hospital of Hebei North UniversityZhangjiakou 075000 HebeiChina State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer MedicineMedical Oncology DepartmentSun Yat-Sen University Cancer CenterGuangzhou 510060 GuangdongChina State Key Laboratory of Medical genomics Shanghai Institute of HematologyNational Research Center for Translational MedicineRuijin Hospital Affiliated with Shanghai Jiao Tong University School of MedicineShanghai 200025China State Key Laboratory of Membrane Biology Institute of ZoologyChinese Academy of Sciences&University of Chinese Academy of SciencesBeijing 100101China Department of Pediatrics Affiliated Hospital of Youjiang Medical University for NationalitiesBaise City 533000 GuangxiChina Department of Hematology Yulin Guinan HospitalYulin 537005 GuangxiChina Department of neurology Wuzhou Gongren HospitalWuzhou 543001 GuangxiChina Guangxi Key Laboratory of Basic Research on Birth Defects Prevention and Treatment Guangxi Zhuang Autonomous Region Women and Children Health Care HospitalNanning 530000 GuangxiChina Department of Hematology Guigang People’s HospitalGuigang 537100 GuangxiChina Department of Hematology Hospital of Traditional Chinese Medicine of Wuzhou CityWuzhou 543002 GuangxiChina Department of Hematology Wuzhou Red Cross HospitalWuzhou 543002 GuangxiChina Department of Hematology Hechi People’s HospitalHechi City 547000 GuangxiChina

Thalidomide inducesγ-globin expression in erythroid progenitor cells,but its efficacy on patients with transfusion-dependentβ-thalassemia(TDT)remains *** this phase 2,multi-center,randomized,double-blind clinical trial,we aimed to determine the safety and efficacy of thalidomide in TDT patients.A hundred patients of 14 years or older were randomly assigned to receive placebo or thalidomide for 12 weeks,followed by an extension phase of at least 36 *** primary endpoint was the change of hemoglobin(Hb)level in the *** secondary endpoints included the red blood cell(RBC)units transfused and adverse *** the placebo-controlled period,Hb concentrations in patients treated with thalidomide achieved a median elevation of 14.0(range,2.5 to 37.5)g/L,whereas Hb in patients treated with placebo did not significantly *** the 12 weeks,the mean RBC transfusion volume for patients treated with thalidomide and placebo was 5.4±5.0 U and 10.3±6.4 U,respectively(Plidomide than *** the extension phase,treatment with thalidomide for 24 weeks resulted in a sustainable increase in Hb concentrations which reached 104.9±19.0 g/L,without blood *** increase in Hb concentration and reduction in RBC transfusions were associated with nonβ0/β0 and HBS1L-MYB(rs9399137 C/T,C/C;rs4895441 A/G,G/G)*** results demonstrated that thalidomide is effective in patients with TDT.

关键词： transfusion patients thalidomide

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma(CHANCE001)

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Signal Transduction and Targeted Therapy 2023年第3期8卷 1198-1207页

作者： Hai-Dong zhu Hai-liang li Ming-Sheng Huang Wei-zhu Yang Guo-Wen Yin Bin-Yan Zhong jun-Hui Sun Zhi-Cheng Jin Jian-Jian Chen Nai-Jian ge Wen-Bin Ding Wen-Hui li Jin-Hua Huang Wei Mu Shan-Zhi Gu Jia-Ping li Hui Zhao shu-Wei Wen Yan-Ming Lei Yu-Sheng Song Chun-wang Yuan Wei-Dong wang Ming Huang Wei Zhao Jian-Bing Wu Song wang Xu zhu Jian-jun Han Wei-xin Ren Zai-Ming Lu Wen-ge xing Yong Fan Hai-lan lin Zi-shu Zhang Guo-Hui Xu Wen-Hao Hu Qiang Tu Hong-ying Su Chuan-Sheng Zheng Yong Chen Xu-Ya Zhao zhu-Ting Fang Qi wang Jin-Wei Zhao Ai-Bing Xu Jian Xu Qing-Hua Wu Huan-Zhang Niu Jian wang Feng Dai Dui-Ping Feng Qing-Dong li rong-shu Shi Jia-Rui li Guang Yang Hai-Bin Shi Jian-Song Ji Yu-E liu Zheng Cai Po Yang Yang Zhao xiao-li zhu li-Gong Lu Gao-jun Teng Center of Interventional Radiology&Vascular Surgery Department of RadiologyZhongda HospitalMedical SchoolSoutheast UniversityNanjing 210009China Department of Minimally invasive Intervention The Affiliated Cancer Hospital of Zhengzhou UniversityZhengzhou 450008China Department of Interventional Radiology the Third Affiliated HospitalSun Yat-Sen UniversityGuangzhou 510630China Department of Interventional Radiology Union Hospital of Fujian Medical UniversityFuzhou 350001China Department of Interventional Radiology Jiangsu Cancer Hospital&Jiangsu Institute of Cancer Research&The Affiliated Cancer Hospital of Nanjing Medical UniversityNanjing 210009China Department of Interventional Radiology The First Affiliated Hospital of Soochow UniversitySoochow UniversitySuzhou 215006China Hepatobiliary and Pancreatic Interventional Treatment Center Division of Hepatobiliary and Pancreatic SurgeryThe First Affiliated HospitalZhejiang University School of MedicineHangzhou 310003China Department of Interventional Radiology Eastern Hospital of Hepatobiliary SurgeryNavy Medical University(Second Military Medical University)Shanghai 200438China Department of Interventional Radiology Nantong First People’s HospitalNantong 226001China Department of Interventional Radiology Yancheng Third People’s HospitalYancheng 224008China Department of Minimally Invasive Interventional Therapy Sun YatSen University Cancer CenterGuangzhou 510060China Department of Vascular Surgery Southwest HospitalThird Military Medical University(Army Medical University)Chongqing 400038China. Department of Interventional Radiology Hunan Cancer HospitalChangsha 410031China Department of Interventional Oncology The First Affiliated Hospital of Sun Yat-sen UniversityGuangzhou 510080China Department of Interventional Radiology The Hospital of Nantong UniversityNantong 226001China Department of Interventional Therapy Shanxi Tumor HospitalTaiyuan 030001China Department of Interventional Radiology Tibet Autonomous Region People’s

There is considerable potential for integrating transarterial chemoembolization(TACE),programmed death-(ligand)1(PD-[L]1)inhibitors,and molecular targeted treatments(MTT)in hepatocellular carcinoma(HCC).It is necessary to investigate the therapeutic efficacy and safety of TACE combined with PD-(L)1 inhibitors and MTT in real-world *** this nationwide,retrospective,cohort study,826 HCC patients receiving either TACE plus PD-(L)1 blockades and MTT(combination group,n=376)or TACE monotherapy(monotherapy group,n=450)were included from January 2018 to May *** primary endpoint was progression-free survival(PFS)according to modified *** secondary outcomes included overall survival(OS),objective response rate(ORR),and *** performed propensity score matching approaches to reduce bias between two *** matching,228 pairs were included with a predominantly advanced disease *** PFS in combination group was 9.5 months(95%confidence interval[CI],8.4-11.0)versus 8.0 months(95%CI,6.6-9.5)(adjusted hazard ratio[HR],0.70,P=0.002).OS and ORR were also significantly higher in combination group(median OS,19.2[16.1-27.3]vs.15.7 months[13.0-20.2];adjusted HR,0.63,P=0.001;ORR,60.1%vs.32.0%;Pgest that TACE plus PD-(L)1 blockades and MTT could significantly improve PFS,OS,and ORR versus TACE monotherapy for Chinese patients with predominantly advanced HCC in real-world practice,with an acceptable safety profile.

关键词： hepatocellular targeted matching

Data release of the LAMOST pilot survey

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Research in Astronomy and Astrophysics 2012年第9期12卷 1243-1246页

作者： A-li Luo Hao-Tong Zhang Yong-Heng Zhao Gang Zhao Xiang-Qun Cui Guo-Ping li Yao-Quan Chu Jian-rong Shi Gang wang Jian-Nan Zhang Zhong-Rui Bai xiao-Yan Chen Feng-Fei wang Yan-xin Guo Jian-jun Chen Bing Du xiao Kong Ya-Juan Lei Yin-Bi li Yi-Han Song Yue Wu Yan-Xia Zhang xin-lin Zhou Fang Zuo Peng Du lin He Wen Hou Yi-Qiao Dong Jian li Guang-Wei li shuang li Jing Song Yuan Tian Meng-xin wang Yong-Hui Hou Zhi-ying Huo Hong-zhuan Hu Ning-Sheng Hu Zhong-Wen Hu Lei Jia Fang-Hua Jiang Xiang Jiang Zi-Bo Jiang ge Jin Ai-Hua li Qi li Yin-Dun Mao Zheng-Hong Tang Qing-Sheng Tao liang-Ping Tu Da-Qing wang Dan wang Jian-Ping wang Lei wang Shou-Guan wang shu-Qing wang Ya-Nan wang You wang Yue-Fei wang Ming-Zhi Wei Xiang-Xiang Xue xiao-Zheng xing ling-Zhe Xu xin-Qi Xu Yan Xu De-Hua Yang Shi-Hai Yang Zheng-Qiu Yao Yong Yu Hui Yuan Chao Zhai En-Peng Zhang Jing Zhang li-Ping Zhang WeiZhang Yong Zhang Zhen-Chao Zhang Ming Zhao Fang Zhou Yong-Tian zhu Jie zhu Si-Cheng Zou National Astronomical Observatories Chinese Academy of Sciences Beijing 100012 China lal @ lamost o rg Nanjing Institute of Astronomical Optics and Technology National Astronomical ObservatoriesChinese Academy of Sciences Nanjing 210042 China University of Science and Technologyof China Hefei 230026 China Shanghai Astronomical Observatory Chinese Academy of Sciences Shanghai 200030 China Institute of Architecture Design and Research Chinese Academy of Sciences Beijing 100190China

This paper describes the data release of the LAMOST pilot survey, which includes data reduction, calibration, spectral analysis, data products and data access. The accuracy of the released data and the information about the FITS headers of spectra are also introduced. The released data set includes 319 000 spectra and a catalog of these objects.

关键词： techniques: spectroscopic survey — data reduction — data release

The first data release(DR1) of the LAMOST regular survey

在线全文

学校读者我要写书评

暂无评论

Research in Astronomy and Astrophysics 2015年第8期15卷 1095-1124页

作者： A-li Luo Yong-Heng Zhao Gang Zhao li-Cai Deng xiao-Wei liu Yi-Peng Jing Gang wang Hao-Tong Zhang Jian-rong Shi Xiang-Qun Cui Yao-Quan Chu Guo-Ping li Zhong-Rui Bai Yue Wu Yan Cai shu-Yun Cao Zi-Huang Cao Jeffrey L.Carlin Hai-Yuan Chen Jian-jun Chen Kun-xin Chen li Chen Xue-Lei Chen xiao-Yan Chen ying Chen Norbert Christlieb Jia-Ru Chu Chen-Zhou Cui Yi-Qiao Dong Bing Du Dong-Wei Fan Lei Feng Jian-Ning Fu Peng Gao Xue-Fei Gong Bo-Zhong Gu Yan-xin Guo Zhan-Wen Han Bo-liang He Jin-liang Hou Yong-Hui Hou Wen Hou Hong-zhuan Hu Ning-Sheng Hu Zhong-Wen Hu Zhi-ying Huo Lei Jia Fang-Hua Jiang Xiang Jiang Zhi-Bo Jiang ge Jin xiao Kong Xu Kong Ya-Juan Lei Ai-Hua li Chang-Hua li Guang-Wei li Hai-Ning li Jian li Qi li shuang li Sha-Sha li xin-Nan li Yan li Yin-Bi li Ye-Ping li Yuan liang Chien-Cheng lin Chao liu gen-rong liu Guan-Qun liu Zhi-Gang liu Wen-Zhi Lu Yu Luo Yin-Dun Mao Heidi Newberg Ji-jun Ni Zhao-Xiang Qi Yong-jun Qi Shi-Yin Shen Huo-Ming Shi Jing Song Yi-Han Song Ding-Qiang Su Hong-jun Su Zheng-Hong Tang Qing-Sheng Tao Yuan Tian Dan wang Da-Qi wang Feng-Fei wang Guo-Min wang Hai wang Hong-Chi wang Jian wang Jia-Ning wang Jian-ling wang Jian-Ping wang jun-Xian wang Lei wang Meng-xin wang Shou-Guan wang shu-Qing wang Xia wang Ya-Nan wang You wang Yue-Fei wang You-Fen wang Peng Wei Ming-Zhi Wei Hong Wu Ke-Fei Wu Xue-Bing Wu Yu-Zhong Wu xiao-Zheng xing ling-Zhe Xu xin-Qi Xu Yan Xu Tai-Sheng Yan De-Hua Yang Hai-Feng Yang Hui-Qin Yang Ming Yang Zheng-Qiu Yao Yong Yu Hui Yuan Hai-Bo Yuan Hai-Long Yuan Wei-Min Yuan Chao Zhai En-Peng Zhang Hua-Wei Zhang Jian-Nan Zhang li-Pin Zhang Wei Zhang Yong Zhang Yan-Xia Zhang Zheng-Chao Zhang Ming Zhao Fang Zhou Xu Zhou Jie zhu Yong-Tian zhu Si-Cheng Zou Fang Zuo National Astronomical Observatories Chinese Academy of Sciences Department of Astronomy Peking University Shanghai Astronomical Observatory Chinese Academy of Sciences Nanjing Institute of Astronomical Optics & Technology National Astronomical ObservatoriesChinese Academy of Sciences University of Science and Technology of China Department of Physics Applied Physics and AstronomyRensselaer Polytechnic InstituteTroyNY 12180USA Department of Physics and Astronomy Earlham CollegeRichmondIN 47374USA Universitt Heidelberg Zentrum für AstronomieLandessternwarteKnigstuhl 1269117 HeidelbergGermany Department of Astronomy Beijing Normal University Yunnan Observatories Chinese Academy of Sciences Purple Mountain Observatory Chinese Academy of Sciences

The Large sky Area Multi-Object Fiber Spectroscopic Telescope（LAMOST） general survey is a spectroscopic survey that will eventually cover approximately half of the celestial sphere and collect 10 million spectra of stars, galaxies and QSOs. Objects in both the pilot survey and the first year regular survey are included in the LAMOST DR1. The pilot survey started in October 2011 and ended in june 2012, and the data have been released to the public as the LAMOST Pilot Data Release in August 2012. The regular survey started in September 2012, and completed its first year of operation in june 2013. The LAMOST DR1 includes a total of 1202 plates containing 2 955 336 spectra, of which 1 790 879 spectra have observed signalto-noise ratio（SNR） ≥ 10. All data with SNR ≥ 2 are formally released as LAMOST DR1 under the LAMOST data policy. This data release contains a total of 2 204 696 spectra, of which 1 944 329 are stellar spectra, 12 082 are galaxy spectra and 5017 are quasars. The DR1 not only includes spectra, but also three stellar catalogs with measured parameters： late A,FGK-type stars with high quality spectra（1 061 918 entries）, A-type stars（100 073 entries）, and M-type stars（121 522 entries）. This paper introduces the survey design, the observational and instrumental limitations, data reduction and analysis, and some caveats. A description of the FITS structure of spectral files and parameter catalogs is also provided.

关键词： techniques: spectroscopic survey—data release—catalog

Consensus statement on layout and delivery of automatic external defibrillator in China

在线全文

学校读者我要写书评

暂无评论

Journal of Hainan Medical University 2020年第15期26卷 18-23页

作者： Yu Cao Song Chen Yan-Fen Chai xiao-Hui Chen Yu-Guo Chen Shao-Wen Cheng Wen-Wei Cheng Bang-Han Ding Yang Deng Jie Fu Bang-Jiang Fang Mai-ying Fan li Gui Ping Gong Wei Guo shu-Bin Guo liang Huang Ji-Yuan Han Zhong Ji Xian-Fei Ji xin-Cai Ji Hong-Xu Jin xin-jun Jiang wang-Xiang Jiang Jia-liang liu xiao-Ran liu Zhi liu Chuan-zhu Lv Feng Lu Tan-Shi li xin li Yong li Shang-Lun li shuang-Ming li xiao-Gang li bao-jun li Pei-Wu li Chun-Sheng li Zhi-jun li Chang-Luo li Xiang-Min li Yin-Ping li Zong-jun Lu Zu-Xun Lu Zhong-Qiu Lu Zhi-Qian Luo xiao-xing liao Jian-Bo Lei Tao Ma Yu Ma Yue-Feng Ma Qing-Bian Ma lin-Hao Ma jun-Qi Ma Shi-Nan Nie Jie-Miao Ou-Yang Peng Peng Qiao Pei shu-Ming Pan Guo-Zhong Qing li-Jie Qin Wu-ying Qiao Fei Shao Wei Song xing-Yue Song Zhen-Ju Song rong-Ju Sun De-Ya Shang Du-Juan Sha Gui-lan Tao Guo-Gang Tian ying-Ping Tian Jian-Guang Tian Chao-Yang Tong Zi-Ren Tang Meng-Xiong Tang Guo-Ping Wu Zhi Wan Tao wang xin wang Peng wang Zhong wang Tong wang Ri-xing wang Yi-xin wang xiao-Dan wang ling Wu Wei Wei Hua Xiang Feng Xu jun Xu Jie Xu Miao-rong Xie shuo-Gui Xu Tie Xu Feng Yu Wen Yi li-Shan Yang Shi-Jiao Yan Jin-Jian Yao Shou-Chun Yan Xue-Zhong Yu Xian-Zhi Ye Xian-liang Yan Fu-Bing Zhou rong-Bin Zhou Ming Zhou Qiang Zhou Jin Zhou Ping Zhou Chang-Ju zhu Hua-Dong zhu Ji-Hong zhu Hong Zhang Mao Zhang Hua Zhang Na Zhang Guo-Qiang Zhang Guo-Xiu Zhang Jin-Song Zhang Wen-Wu Zhang Wen-Zhong Zhang Jian-Feng Zhang Yi-Min zhu jun Zeng Yuan Zheng Zhi-Jie Zheng Shen Zhao Yan Zhao Min Zhao Bin Zhao xiao-Dong Zhao xiao-Jing Zhao Hong-Ke Zeng Sheng-Qiang Zou The Chinese Society of Emergency Medicine Research Unit of Island Emergency Medicine Chinese Academy of Medical SciencesHainan Medical University Key Laboratory of Emergency and Trauma of Ministry of Education Hainan Medical UniversityHaikouHainanChina Emergency and Trauma College Hainan Medical UniversityHaikouHainanChina Department of Emergency Hainan Clinical Research Center for Acute and Critical DiseasesThe Second Affiliated Hospital of Hainan Medical UniversityHaikouHainanChina Key Laboratory of Hainan Trauma and Disaster Rescue Key Laboratory of Trauma of Hainan Medical University

*** Sudden cardiac death(SCD)refers to sudden death due to a variety of cardiac *** is manifested as a sudden loss of consciousness,cardiac arrest,and respiratory arrest and generally shows early symptoms that are atypical and not easily detected[1].According to a recent study,nearly 544000 patients suffer from SCD every year in China[2].

关键词： cardiac death respiratory

中国散裂中子源反角白光中子束流参数的初步测量

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

物理学报 2019年第8期68卷 38-49页

作者：鲍杰陈永浩张显鹏栾广源任杰王琦阮锡超张凯安琪白怀勇曹平陈琪萍程品晶崔增琪樊瑞睿封常青顾旻皓郭凤琴韩长材韩子杰贺国珠何泳成何越峰黄翰雄黄蔚玲黄锡汝季筱路吉旭阳江浩雨蒋伟敬罕涛康玲康明涛兰长林李波李论李强李晓李阳李样刘荣刘树彬刘星言马应林宁常军聂阳波齐斌斌宋朝晖孙虹孙晓阳孙志嘉谭志新唐洪庆唐靖宇王鹏程王涛峰王艳凤王朝辉王征文杰温中伟吴青彪吴晓光吴煊解立坤羊奕伟杨毅易晗于莉余滔于永积张国辉张旌张林浩张利英张清民张奇伟张玉亮张志永赵映潭周良周祖英朱丹阳朱科军朱鹏中国原子能科学研究院核数据重点实验室北京102413 中国科学院高能物理研究所北京100049 东莞中子科学中心东莞523803 西北核技术研究所西安710024 核探测与核电子学国家重点实验室北京100049 中国科学技术大学近代物理系合肥230026 核物理与核技术国家重点实验室北京大学物理学院北京100871 中国工程物理研究院核物理与化学研究所绵阳621900 南华大学衡阳421001 中国科学技术大学工程与应用物理系合肥230026 兰州大学核科学与技术学院兰州730000 北京航空航天大学北京100083 西安交通大学西安710049

中国散裂中子源(CSNS)已于2018年5月建设完工,随后进行了试运行.其中的反角白光中子束线(Back-n)可用于中子核数据测量、中子物理研究和核技术应用等多方面的实验.本文报道对该中子束的品质参数测量实验过程以及最终实验结果.实验主要... 详细信息

中国散裂中子源(CSNS)已于2018年5月建设完工,随后进行了试运行.其中的反角白光中子束线(Back-n)可用于中子核数据测量、中子物理研究和核技术应用等多方面的实验.本文报道对该中子束的品质参数测量实验过程以及最终实验结果.实验主要采用中子飞行时间法,利用^(235)U,^(238)U裂变室和~6li-Si探测器测量了中子能谱和中子注量率,又利用闪烁体-互补金属氧化物半导体探测系统测量了中子束斑的剖面,得到了该束线的初步实验测量结果.其中白光中子的全能谱测量范围eV—100 MeV,给出了不确定度分析;给出了中子注量率两个实验厅位置的满功率值;给出了白光中子在直径60 mm情况下的全能区束斑.通过与模拟结果的比较探讨了以上结果的合理性,并提出了改进计划.这些实验结果为以后该束线的核数据测量和探测器标定实验奠定了基础.

关键词：中国散裂中子源反角白光中子中子飞行时间法中子束线特征参数

肺结核住院患者并发肺外结核状况及其与性别和年龄相关性的多中心研究

在线全文

学校读者我要写书评

暂无评论

中国防痨杂志 2020年第6期42卷 563-569页

作者：于佳佳李亮杜建陈鸿雁刘健雄马金山李明武秦敬民舒薇宗佩兰严晓峰张义董永康杨之怡梅早仙邓群益王璞韩文革吴妹英陈玲赵新国谭雷李福建郑超刘宏伟李昕洁阿尔泰杜映荣刘风林杨松崔文玉王全红陈晓红韩骏峰谢清尧冯燕梅刘文玉唐佩军张建勇郑建陈大为姚向阳任彤李艳李媛媛吴磊宋强杨梅张健刘媛媛郭述良严琨沈兴华雷丹张艳丽康万里唐神结首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所结核病多学科诊疗中心 101149 沈阳市胸科医院结核科广州市胸科医院新疆维吾尔自治区胸科医院昆明市第三人民医院结核科山东省胸科医院江西省胸科医院(第三人民医院) 重庆市公共卫生医疗救治中心长春市传染病医院太原市第四人民医院福州肺科医院结核科天津市海河医院结核科深圳市第三人民医院结核科重庆医科大学附属第一医院呼吸与危重症医学科山东省潍坊市第二人民医院结核科苏州市第五人民医院遵义医学院附属医院结核科江苏省无锡市第五人民医院结核科吉林省四平市结核病医院结核科河北省保定市传染病医院结核科厦门大学附属第一医院结核科

目的探讨住院肺结核患者并发肺外结核的发生情况及其与性别、年龄的关系。方法采用观察性研究方法,由参加过统一培训的调查员从医院信息管理系统(HIS系统)收集2011年1月1日至2017年12月31日我国15省21家医疗机构360187例住院肺结核患者... 详细信息

目的探讨住院肺结核患者并发肺外结核的发生情况及其与性别、年龄的关系。方法采用观察性研究方法,由参加过统一培训的调查员从医院信息管理系统(HIS系统)收集2011年1月1日至2017年12月31日我国15省21家医疗机构360187例住院肺结核患者的性别、年龄,以及结核病灶累及部位等信息,比较分析肺结核患者并发肺外结核的发生情况及其与性别、年龄的关系。结果360187例肺结核患者中,男238910例(66.33%),女121277(33.67%),年龄中位数(四分位数)[M(Q1,Q3)]为47(28,62)岁;42987例(11.93%)并发肺外结核,并发率依次为结核性脑膜炎[2.72%(9809例)]、颈部淋巴结结核[1.93%(6966例)]、结核性腹膜炎[1.59%(5733例)]、结核性心包炎[0.94%(3399例)]、肠结核[0.94%(3380例)]等。男性肺结核患者并发结核性脑膜炎、颈部淋巴结结核、结核性腹膜炎、结核性心包炎、结核性多浆膜炎、腰椎结核、胸椎结核、胸壁结核的并发率分别为2.44%(5829例)、1.44%(3429例)、1.41%(3376例)、0.90%(2138例)、0.75%(1791例)、0.67%(1604例)、0.64%(1522例)、0.60%(1438例),均明显低于女性[分别为3.28%(3980例)、2.92%(3537例)、1.94%(2357例)、1.04%(1261例)、0.90%(1093例)、0.79%(960例)、0.76%(924例)、0.66%(805例)](χ2=215.235,930.541,144.480,18.061,23.272,16.442,18.585,4.976;P值均<0.05)。不同年龄组(1~岁组至≥65岁组)肺结核患者并发结核性脑膜炎、颈部淋巴结结核、结核性腹膜炎、肠结核、结核性心包炎、结核性多浆膜炎、腰椎结核、胸椎结核、胸壁结核、咽喉结核的并发率差异均有统计学意义(χ2=3870.549,2939.502,1830.620,673.372,115.428,319.078,52.512,19.308,439.177,136.619;P值均<0.05)。除胸椎结核的并发率未呈现出随年龄变化的趋势(χ趋势2=0.814,P=0.367),结核性心包炎呈现出随年龄增长而增高的趋势(χ趋势2=62.087,P<0.001)外,其他肺外结核的发生率均呈现出随年龄增长而降低的趋势(P值均<0.001)。多因素logistic回归分析结果显示,肺结核并发肺外结核患者的风险女性高于男性[(OR(95%CI)=1.325(1.297~1.353)];其他各年龄组风险均高于≥65岁年龄组[1~岁组、15~岁组、25~岁组、35~岁组、45~岁组、55~岁组的OR(95%CI)值分别为:4.995(4.655~5.360)、2.481(2.397~2.568)、2.053(1.982~2.126)、1.683(1.619~1.749)、1.276(1.228~1.326)、1.109(1.067~1.153)];在控制了性别的影响后,肺结核并发肺外结核患者的风险随年龄的增长而降低[OR(95%CI)=0.817(0.812~0.821)]。结论肺结核患者可并发结核性脑膜炎、颈部淋巴结结核、结核性腹膜炎、结核性心包炎和肠结核等多种肺外结核;且并发肺外结核的风险女性高于男性,并呈现出随年龄的增长而降低的趋势。

关键词：结核,肺结核,肺外性别分布年龄分布因素分析,统计学因果律多中心研究